For the quarter ending 2025-09-30, IART made $402,062,000 in revenue. -$5,404,000 in net income. Net profit margin of -1.34%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenue, net | 402,062,000 | 415,605,000 | 382,653,000 | 409,897,666.667 |
| Cost of goods sold | 195,071,000 | 206,273,000 | 188,221,000 | 182,623,333.333 |
| Research and development | 22,456,000 | 26,997,000 | 24,728,000 | 29,314,000 |
| Selling, general and administrative | 169,046,000 | 179,890,000 | 181,497,000 | 179,930,000 |
| Intangible asset amortization | 3,728,000 | 3,754,000 | 3,704,000 | 5,843,333.333 |
| Goodwill impairment charge | 0 | 511,365,000 | - | - |
| Total costs and expenses | 390,301,000 | 928,279,000 | 398,150,000 | 397,710,666.667 |
| Operating income (loss) | 11,761,000 | -512,674,000 | -15,497,000 | 12,187,000 |
| Interest income | 4,982,000 | 4,710,000 | 4,420,000 | 4,997,000 |
| Interest expense | 22,725,000 | 21,042,000 | 18,815,000 | 17,086,333.333 |
| Other (expense) income, net | -842,000 | -1,946,000 | -144,000 | 610,666.667 |
| Loss before income taxes | -6,824,000 | -530,952,000 | -30,036,000 | 708,333.333 |
| Benefit for income taxes | -1,420,000 | -46,879,000 | -4,743,000 | -542,000 |
| Net loss | -5,404,000 | -484,073,000 | -25,293,000 | 1,250,333.333 |
| Basic (in dollars per share) | -0.07 | -6.31 | -0.33 | 0.017 |
| Basic (in shares) | 76,753,000 | 76,695,000 | 76,463,000 | 187,333.333 |
| Diluted (in dollars per share) | -0.07 | -6.31 | -0.33 | 0.017 |
| Diluted (in shares) | 76,753,000 | 76,695,000 | 76,463,000 | 187,333.333 |
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)